False positive endobronchial ultrasound-guided real-time transbronchial needle aspiration secondary to bronchial carcinoma in situ at the point of puncture: a case report by José Sanz-Santos et al.
Sanz-Santos et al. Journal of Cardiothoracic Surgery 2012, 7:74
http://www.cardiothoracicsurgery.org/content/7/1/74CASE REPORT Open AccessFalse positive endobronchial ultrasound-guided
real-time transbronchial needle aspiration
secondary to bronchial carcinoma in situ at the
point of puncture: a case report
José Sanz-Santos1,2*, Felipe Andreo1,3, Pere Serra1, María Llatjós4, Eva Castellà4, Julio Astudillo5,
Eduard Monsó2,3,6 and Juan Ruiz-Manzano1,2Abstract
Since the development of endobronchial ultrasound-guided real-time needle aspiration (EBUS-rt-TBNA) no false
positive (FP) cases have been described. We present the first FP case for EBUS-rt-TBNA secondary to a
carcinoma in situ (CIS) in the bronchial point of puncture. A 66-years-old male was referred to our Institution
because of a mass in left lower lobe. The bronchoscopy did not show any endobronchial lesion. The cytology
of the washing confirmed an unspecified non-small cell lung cancer. An EBUS-rt-TBNA for staging was carried
out. No mediastinal nodes over 5 mm length were found but one single left hilar node at station 11 L was
sampled. The cytology of the TBNA showed lymphocytes and neoplastic squamous cells. The patient underwent
thoracotomy. On the surgical specimen no metastasis on any of the nodes resected were detected but a CIS
on the bronchial resection margin was described. A bronchial biopsy confirmed CIS on the bronchial stump.
The reported case depicts an unusual situation, we consider EBUS-rt-TBNA an accurate technique if minimal
requirements are met
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Endobronchial ultrasound-guided real-time transbron-
chial needle aspiration (EBUS-rt-TBNA) is a relatively
novel technique that has proven useful in lung cancer
diagnosis and staging. EBUS-rt-TBNA can be performed
under conscious sedation in an outpatient setting. Sev-
eral studies have demonstrated that EBUS-rt-TBNA is
an accurate procedure alternative to surgical staging,
with fewer complications and similar figures for sensitiv-
ity and specificity. While an average false-negative rate
of 10 % represents a handicap for this procedure, no
false-positive (FP) cases have been described. We present
the first FP case of EBUS-rt-TBNA.* Correspondence: jsanzsantos@gmail.com
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A 66-year-old male, with a 40 pack-year smoking his-
tory, consulted his general practitioner because of per-
sistent cough lasting for 3 months. A chest x-ray was
performed and a mass on left lower lobe (LLL) was
detected. The patient was then referred to our Institu-
tion. The thoracic CT-scan confirmed the presence of a
peripheral mass on LLL (4x3 cm), without evidence of
nodal enlargement (Figure 1). A white light bronchos-
copy was performed and no endobronchial lesions were
detected. The bronchial washing cytology was positive
for unspecified non-small cell lung cancer. An EBUS-rt-
TBNA for staging was performed. There were no nodes
over 5 mm in short-axis diameter on mediastinal sta-
tions but one left hilar node, at 11 L station, measuring
12x9 mm was detected and sampled. The cytological
examination of the smear showed the presence of lym-
phocytes and a few groups of neoplastic squamous cells
(Figure 2a). The patient was diagnosed with squamous-ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Thoracic CT-scan: Peripheral mass in left lower lobe
with central cavitation.
Figure 2 a: Transbronchial lymph node aspiration specimen:
cluster of neoplastic squamous cells (no lymphocytes in this
field) (Papanicolau stain, x400) b: Surgical specimen: carcinoma
in situ (CIS) on the bronchial resection margin
(Haematoxylin&Eosin stain, x400).
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went left lower lobe lobectomy. The surgical specimen
consisted of a peripheral mass in LLL measuring 4x3
cm consistent with SCC, carcinoma in situ (CIS) on
the bronchial resection margin (Figure 2b) without
nodal involvement of any of the 9 nodes resected.
Several cuts of the hilar nodes were carried out but
no neoplastic cells were detected. The postsurgical
staging was pT2aN0M0 with CIS on the bronchial
resection margin. A few weeks later a bronchoscopy
with autofluorescence was performed. An area of low
autofluorescence extending from the lobectomy stump
to the main left bronchus was detected; the bron-
chial biopsy confirmed the CIS. The CIS was treated
twice with endobronchial argon plasma coagulation.
Due to local recurrence, the patient finally underwent
pneumonectomy.Discussion
Since the development of transbronchial needle aspir-
ation (TBNA) for flexible bronchoscopy for lung cancer
staging in the eighties, false-positives (FP) have been
rarely reported. A case is considered as FP when tumor
cells are identified on transbronchial lymph node aspir-
ation but tumor metastases are not found in nodes
obtained by thoracotomy or mediastinoscopy. Probably
the exceptionality of FP in TBNA sampling is an accur-
ate estimation but not all the studies confirmed positive
TBNA results with further invasive procedures. When
the technique was first described [1] it was recom-
mended to perform the TBNA prior to any manipulation
in order to minimize the risk of contamination of the as-
piration specimen and then avoid potential false-positive
results.
Cropp [2] and cols were the first investigators to de-
scribe a false positive in a TBNA sampling. These
authors postulated that tumor cells exfoliated from
bronchogenic carcinoma could be located on the
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the tracheal wall and could therefore be collected during
aspiration. Other authors described a FP case probably
secondary to tumor sampling instead of lymph node [3].
For this reason, special care was recommended when an
aspiration harboured neoplastic cells but no lympho-
cytes, especially in patients with minor radiological sus-
picion. Other cases of FP TBNA were attributed to
needle contamination but overall TBNA has been con-
sidered highly reliable and FP have been considered clin-
ically non-significant [4].
With the emergence of echo-probes for radial EBUS
the accuracy of TBNA procedures increased and only
one case of FP was registered in a series of Okamoto
et al. [5] Since the introduction of echobronchoscopes,
that provide real time assistance to TBNA no false-
positive transbronchial lymph node aspirates have been
described in any series, and consequently a specificity of
100 % has been conferred to this technique. Although,
as previously, only a few studies performed with EBUS-
rt-TBNA confirmed positive results with mediastino-
scopy or thoracotomy.
EBUS allows real time guidance of the puncture avoid-
ing incidental sampling of masses. The needle used for
EBUS-rt-TBNA incorporates a stylet in the inner chan-
nel that prevents contamination. The only potential sce-
nario for FP results of EBUS-rt-TBNA is the use of a
single needle to sample more than one node after a posi-
tive result.
To our knowledge, the present case is the first FP
documented for EBUS-rt-TBNA and is the first attribu-
ted to needle contamination by neoplastic cells from a
bronchial CIS on the puncture point. As a mechanism
similar to that suggested by Cropp and cols, probably
malignant squamous cells from the CIS were intro-
duced during the puncture and then aspirated. During
the procedure the syringe suction was always attached
and released just when the needle was inside the
lymph node. Consequently, we do not consider inci-
dental suction of the bronchial wall as a possible ex-
planation for this case. Fortunately, in our patient the
FP had no consequences on the staging that could
change the choice of treatment. CIS are frequent in
smoking patients with lung neoplasm, may be multi-
centric and difficult to identify with white light bron-
choscopy [6].
Conclusions
The present case represents a fortuitous coincidence
that might be considered when obtained results are
contradictory in patients with squamous lung carcinoma.
EBUS-rt-TBNA is a highly specific technique with a very
low risk of contamination if minimal requirements are
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